{"id":151802,"date":"2020-11-05T09:55:55","date_gmt":"2020-11-05T14:55:55","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/enlivex-receives-notice-of-allowance-for-u-s-patent-application-covering-methods-of-treating-gout-inflammatory-bowel-disease-crohns-disease-and\/"},"modified":"2024-08-18T11:41:28","modified_gmt":"2024-08-18T15:41:28","slug":"enlivex-receives-notice-of-allowance-for-u-s-patent-application-covering-methods-of-treating-gout-inflammatory-bowel-disease-crohns-disease-and","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/enlivex-receives-notice-of-allowance-for-u-s-patent-application-covering-methods-of-treating-gout-inflammatory-bowel-disease-crohns-disease-and.php","title":{"rendered":"Enlivex Receives Notice of Allowance for U.S. Patent Application Covering Methods of Treating Gout, Inflammatory Bowel Disease, Crohn\u2019s Disease, and&#8230;"},"content":{"rendered":"<p><![CDATA[Nes-Ziona, Israel, Nov.  05, 2020  (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the \u201cCompany\u201d), a clinical-stage immunotherapy company, today announced that the U.S. Patent and Trademark Office issued a notice of allowance for a new patent application covering methods of using Allocetra\u2122, the company\u2019s immunotherapy product candidate.\u00a0 Upon issuance, the new patent will provide added intellectual property protection for methods of treating autoimmune and inflammatory diseases comprising gout, inflammatory bowel disease, Crohn\u2019s disease, and ulcerative colitis. The company expects that this new patent will be issued in the United States in the coming months.]]><\/p>\n<p>View post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/11\/05\/2121090\/0\/en\/Enlivex-Receives-Notice-of-Allowance-for-U-S-Patent-Application-Covering-Methods-of-Treating-Gout-Inflammatory-Bowel-Disease-Crohn-s-Disease-and-Ulcerative-Colitis-with-Allocetra-I.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Enlivex Receives Notice of Allowance for U.S. Patent Application Covering Methods of Treating Gout, Inflammatory Bowel Disease, Crohn\u2019s Disease, and...\">Enlivex Receives Notice of Allowance for U.S. Patent Application Covering Methods of Treating Gout, Inflammatory Bowel Disease, Crohn\u2019s Disease, and...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>View post: Enlivex Receives Notice of Allowance for U.S. Patent Application Covering Methods of Treating Gout, Inflammatory Bowel Disease, Crohn\u2019s Disease, and... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/enlivex-receives-notice-of-allowance-for-u-s-patent-application-covering-methods-of-treating-gout-inflammatory-bowel-disease-crohns-disease-and.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-151802","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/151802"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=151802"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/151802\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=151802"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=151802"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=151802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}